# Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects

> **NCT00847925** · PHASE1,PHASE2 · COMPLETED · sponsor: **Renovo** · enrollment: 103 (actual)

## Conditions studied

- Cicatrix

## Interventions

- **DRUG:** Avotermin (RN1001)

## Key facts

- **NCT ID:** NCT00847925
- **Lead sponsor:** Renovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2003-09
- **Final completion:** 2003-09
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2009-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847925, "Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00847925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*